3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Recruiting
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Overweight
1
Obesity
1
Lung Neoplasms
1
HER2+ Metastatic Breast Cancer (MBC)
1
Diabetes Mellitus
1
Carcinoma, Hepatocellular
1
Interventions
Cisplatin
7
Paclitaxel
5
Radiotherapy
4
Platinum
3
zimberelimab
2
pembrolizumab
2
nimotuzumab
2
lenvatinib
2
camrelizumab
2
Taxes
2
Injections
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Drug Therapy
2
Carboplatin
2
Brachytherapy
2
zanidatamab
1
trilaciclib
1
toripalimab
1
tislelizumab
1
sintilimab
1
neratinib
1
fludarabine
1
envafolimab
1
Watchful Waiting
1
Ultrasonography, Doppler
1
Transurethral Resection of Prostate
1
Therapeutics
1
Telemedicine
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Uterine Cervical Neoplasms
×
Patient Navigation
×
Clear all
NCT07351110
2026-01-20
PINPOINT
University of Florida
Phase NA
Not yet recruiting
20 enrolled